【24h】

Gene therapy for autoimmune disease.

机译:自身免疫性疾病的基因治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

Autoantigen-specific CD4(+) T lymphocytes have been implicated in the pathogenesis of autoimmune diseases. Tissue-specific homing properties of autoantigen-specific CD4(+) T cells suggested that these cells might be ideal vehicles for delivery of retroviral-encoded regulatory proteins in a site-specific manner as a therapy for autoimmune diseases. Application of retroviral transduction of autoantigen-reactive CD4(+) T cells in gene therapy of autoimmunity must include systems capable of targeting these rare populations of antigen-activated T cells. Studies discussed below suggest that retroviral transduction of autoantigen-specific murine CD4(+) T cells may provide a method to target and isolate nontransformed autoantigen-specific murine CD4(+) T cells and provide a rational approach to gene therapy in animal models of autoimmunity. Copyright 2000 Academic Press.
机译:自身抗原特异性CD4(+)T淋巴细胞已牵涉到自身免疫性疾病的发病机理中。自身抗原特异性CD4(+)T细胞的组织特异性归巢特性表明,这些细胞可能是以位点特异性方式递送逆转录病毒编码调节蛋白作为治疗自身免疫性疾病的理想载体。自身抗原反应性CD4(+)T细胞的逆转录病毒转导在自身免疫性基因治疗中的应用必须包括能够靶向这些罕见的抗原激活T细胞种群的系统。下文讨论的研究表明,自身抗原特异性鼠CD4(+)T细胞的逆转录病毒转导可能提供靶向和分离未转化的自身抗原特异性鼠CD4(+)T细胞的方法,并为自身免疫动物模型中的基因治疗提供合理的方法。版权所有2000学术出版社。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号